Dylan Kellachan
Education
M.B.A., business analytics, quantitative finance, and strategy, NYU Stern School of Business; B.A., philosophy and English, Boston College
Summary of Experience
Mr. Kellachan applies his experience in quantitative and qualitative analysis to litigation and non-litigation business matters related to antitrust and competition, health care, finance, and commercial disputes. His antitrust and competition experience includes evaluating allegations of reverse-payment settlements between pharmaceutical companies and potential abuse of US Food and Drug Administration (FDA) regulatory frameworks, and assessing damages claims in a variety of industry contexts. His securities and finance work has involved analyzing the merits of clawing back compensation from executives at a national bank following a high-profile scandal and assessing whether executives failed to enable a strong safety culture or disclose risks following adverse events. Mr. Kellachan also has experience with commercial disputes regarding the national distribution and dispensation of controlled substances and the application of organizational theory to matters involving product liability, safety, and risk management. He has supported academic and industry experts through all phases of litigation, including expert search, fact discovery, expert testimony, trial preparation, and settlement negotiations.